Calculus Capital appeared to be the VC, which was created in 1999. The fund was located in Europe if to be more exact in United Kingdom. The main department of described VC is located in the London.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. We can highlight the next thriving fund investment areas, such as Financial Services, Education. Among the most popular portfolio startups of the fund, we may highlight IPV, Once Upon a Time, Jumptastic. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.
The important activity for fund was in 2014. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 1 - 5 millions dollars. Comparing to the other companies, this Calculus Capital performs on 13 percentage points less the average number of lead investments. Considering the real fund results, this VC is 53 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Calculus Capital, startups are often financed by Cambridge Angels group, Oxford Technology Management, SyndicateRoom. The meaningful sponsors for the fund in investment in the same round are Enterprise Investment Scheme, Venture Capital Trust, Scottish Investment Bank. In the next rounds fund is usually obtained by Scottish Investment Bank, ValueAct Capital, Upscale.
This organization was formed by John Glencross, Susan McDonald. The overall number of key employees were 5.
Funds with similar focus
Fund Name | Location |
BaseCamp Ventures | Moorestown, New Jersey, United States |
Ferguson Ventures | Newport News, United States, Virginia |
ICD-PS | Jeddah, Makkah, Saudi Arabia |
Nanjing Zhongyiren Investment | China, Jiangsu, Nanjing |
Newport Coast Investments | California, Newport Beach, United States |
Pharmascience | Canada, Montréal, Quebec |
What If Ventures | Frisco, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
WorkL | $2M | 11 Jun 2024 | London, England, United Kingdom | ||
Tagomics | $9M | 21 Feb 2024 | Cambridge, Massachusetts, United States | ||
MIP Discovery | $9M | 19 Feb 2024 | Bedford, Bedfordshire, United Kingdom | ||
Laverock Therapeutics | $18M | 28 Sep 2023 | - | ||
Arctic Shores | $7M | 16 Jan 2023 | London, England, United Kingdom | ||
Wazoku | $11M | 28 Sep 2022 | London, England, United Kingdom | ||
Optalitix | $5M | 08 Sep 2022 | London, England, United Kingdom | ||
Hinterview | $4M | 03 Dec 2021 | London, England, United Kingdom | ||
Invizius | $7M | 06 May 2021 | City of Edinburgh, Scotland, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
WorkL | $2M | 11 Jun 2024 | London, England, United Kingdom | ||
Tagomics | $9M | 21 Feb 2024 | Cambridge, Massachusetts, United States | ||
MIP Discovery | $9M | 19 Feb 2024 | Bedford, Bedfordshire, United Kingdom | ||
Laverock Therapeutics | $18M | 28 Sep 2023 | - | ||
Arctic Shores | $7M | 16 Jan 2023 | London, England, United Kingdom | ||
Wazoku | $11M | 28 Sep 2022 | London, England, United Kingdom | ||
Optalitix | $5M | 08 Sep 2022 | London, England, United Kingdom | ||
Hinterview | $4M | 03 Dec 2021 | London, England, United Kingdom | ||
Invizius | $7M | 06 May 2021 | City of Edinburgh, Scotland, United Kingdom |